World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
95
Citations
30536
World Ranking
10131
National Ranking
5215

Peter G. Shields publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Peter G. Shields sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 417 publications — 42nd percentile

42% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Peter G. Shields D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Peter G. Shields sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 95 D-Index — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Peter G. Shields is affiliated with The Ohio State University in the United States. Their research primarily falls within the field of Medicine, with a significant focus on Oncology, Pulmonary and Respiratory Medicine, Physiology, Molecular Biology, and Infectious Diseases.

Their recent publications include:

  • Adverse effects of electronic cigarettes on the disease-naive oral microbiome, 2020, Science Advances
  • COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer, 2021, Cancer Cell
  • Prospective Statewide Study of Universal Screening for Hereditary Colorectal Cancer: The Ohio Colorectal Cancer Prevention Initiative, 2021, JCO Precision Oncology
  • E-Cigarette or Vaping Product Use-associated Lung Injury: Developing a Research Agenda. An NIH Workshop Report, 2020, American Journal of Respiratory and Critical Care Medicine
  • Lipid laden macrophages and electronic cigarettes in healthy adults, 2020, EBioMedicine

Frequent co-authors of Peter G. Shields include:

  • Carolyn J. Presley
  • David P. Carbone
  • Dwight H. Owen
  • Gregory A. Otterson
  • Kai He

Shields has contributed extensively to journals such as:

  • Journal of Clinical Oncology
  • Journal of the National Comprehensive Cancer Network
  • Cancer Research
  • Journal of Thoracic Oncology
  • Drug and Alcohol Dependence

Their work covers a range of topics, including:

  • Cancer Immunotherapy and Biomarkers
  • Smoking Behavior and Cessation
  • Inflammatory Biomarkers in Disease Prognosis
  • Lung Cancer Research Studies
  • Lung Cancer Treatments and Mutations
  • Cancer Diagnosis and Treatment
  • SARS-CoV-2 and COVID-19 Research

Best Publications

  • Metabolic gene polymorphism frequencies in control populations.

    S. Garte;L. Gaspari;A.K. Alexandrie;C. Ambrosone

  • Vitamin E Acetate in Bronchoalveolar-Lavage Fluid Associated with EVALI

    Benjamin C Blount;Mateusz P Karwowski;Peter G Shields;Maria Morel-Espinosa

  • Frequent Nitric Oxide Synthase-2 Expression in Human Colon Adenomas: Implication for Tumor Angiogenesis and Colon Cancer Progression

    Stefan Ambs;William G. Merriam;William P. Bennett;Emanuela Felley-Bosco

  • Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease.

    S P Hussain;P Amstad;K Raja;S Ambs

  • Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer.

    Rachel Pearlman;Wendy L Frankel;Benjamin Swanson;Weiqiang Zhao

  • Manganese Superoxide Dismutase (MnSOD) Genetic Polymorphisms, Dietary Antioxidants, and Risk of Breast Cancer

    Christine B. Ambrosone;Jo L. Freudenheim;Patricia A. Thompson;Elise Bowman

  • Evidence suggesting the role of specific genetic factors in cigarette smoking.

    Caryn Lerman;Neil E. Caporaso;Janet Audrain;David Main

  • Cigarette Smoking, N-Acetyltransferase 2 Genetic Polymorphisms, and Breast Cancer Risk

    Christine B. Ambrosone;Jo L. Freudenheim;Saxon Graham;James R. Marshall

  • Genetic polymorphisms in DNA repair genes and risk of lung cancer

    Dorota Butkiewicz;Marek Rusin;Lindsey Enewold;Peter G. Shields

  • Breast Cancer Risk in Premenopausal Women Is Inversely Associated with Consumption of Broccoli, a Source of Isothiocyanates, but Is Not Modified by GST Genotype

    Christine B. Ambrosone;Susan E. McCann;Jo L. Freudenheim;Jo L. Freudenheim;James R. Marshall

  • Cancer Survivorship—Genetic Susceptibility and Second Primary Cancers: Research Strategies and Recommendations

    Lois B. Travis;Charles S. Rabkin;Linda Morris Brown;James M. Allan

  • Circulating Tumor Cells: A Useful Predictor of Treatment Efficacy in Metastatic Breast Cancer

    Minetta C. Liu;Peter G. Shields;Robert D. Warren;Philip Cohen

  • Cancer Risk and Low-Penetrance Susceptibility Genes in Gene-Environment Interactions

    Peter G. Shields;Curtis C. Harris

  • Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk

    Simone Benhamou;Won Jin Lee;Anna Karin Alexandrie;Paolo Boffetta

  • Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation.

    Caryn Lerman;Rachel Tyndale;Freda Patterson;E. Paul Wileyto

  • Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk.

    Christine B. Ambrosone;Jo L. Freudenheim;Saxon Graham;James R. Marshall

  • Novel Nicotine Delivery Systems and Public Health: The Rise of the “E-Cigarette”

    Nathan K. Cobb;M. Justin Byron;David B. Abrams;Peter G. Shields

  • Genetically based N -acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens

    Paolo Vineis;Helmut Bartsch;Neil Caporaso;Anita M. Harrington

  • Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation

    Dorothy K. Hatsukami;Michael Kotlyar;Louise A. Hertsgaard;Yan Zhang

  • Alcohol dehydrogenase 3 genotype and risk of oral cavity and pharyngeal cancers.

    Harty Lc;Caporaso Ne;Hayes Rb;Winn Dm

Frequent Co-Authors

Jo L. Freudenheim
Jo L. Freudenheim University at Buffalo, State University of New York
Christine B. Ambrosone
Christine B. Ambrosone Roswell Park Cancer Institute
Maurizio Trevisan
Maurizio Trevisan Università Campus Bio-Medico di Roma
Curtis C. Harris
Curtis C. Harris National Institutes of Health
Stephen B. Edge
Stephen B. Edge Roswell Park Cancer Institute
Caryn Lerman
Caryn Lerman University of Southern California
David P. Carbone
David P. Carbone The Ohio State University
Neil E. Caporaso
Neil E. Caporaso National Institutes of Health
Dorothy K. Hatsukami
Dorothy K. Hatsukami University of Minnesota
Gregory A. Otterson
Gregory A. Otterson The Ohio State University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring healthcare fields doesn’t always require following the traditional medical school route. Many students are pursuing flexible online programs that open doors to rewarding clinical roles and fast-track career advancement.

Those who already hold a nursing license can boost their qualifications and earning potential by enrolling in the online nursing doctorate programs. These advanced degrees are ideal for nurses seeking leadership positions or careers in research and academia.

For working RNs, the most affordable accredited online rn to bsn programs offer a convenient path to advance their credential and improve patient care skills. Non-nursing majors interested in moving into the field can explore direct entry msn programs for non-nursing majors online, allowing a switch to nursing practice and management roles.

If you’re just starting, online adn programs provide a fast, accessible entry point into nursing. With a wide array of options, online healthcare degrees can provide an efficient, affordable step toward a successful medical career.

Best Scientists Citing Peter G. Shields

Trending Scientists

Recently Published Articles